Skip to main content
. 2019 Oct 17;18(6):6536–6544. doi: 10.3892/ol.2019.10992

Figure 5.

Figure 5.

Inhibition of miR-221-5p expression activates the PI3K/AKT/mTOR signaling pathway. The expression levels of key proteins of the PI3K/AKT/mTOR pathway were detected using western blotting following transfection of myeloma bone disease mesenchymal stem cells with microRNA-221-5p inhibitor. *P<0.05, **P<0.01 vs. NC. AKT, protein kinase B; mTOR, mammalian target of rapamycin; NC, negative control; P-, phosphorylated; PI3K, phosphoinositide 3-kinase.